Media Statement:

CYTOCHROMA MOVES FORWARD DESPITE GENZYME LAWSUIT

August 22, 2006 – Cytochroma Inc. of Markham, Ontario, Canada Canada today issued the following statement in response to a lawsuit filed against company executives August 8, 2006 by Genzyme Corporation of Massachusetts that alleges improper use of intellectual property and related matters:

“The Genzyme lawsuit is without merit and Cytochroma will vigorously defend its position. We are confident that Cytochroma will prevail if this matter ever goes to court.

“Cytochroma and Genzyme are competitors in a large and growing industry, but in no way was Genzyme’s patented or proprietary information, expertise or intellectual property used to further Cytochroma. For Genzyme to suggest otherwise and file this lawsuit, curiously, as Cytochroma is in the midst of pursuing investors, is wrong.

“We believe the facts will show that our managers who are the target of this lawsuit scrupulously complied with their non-compete agreements and acted with integrity. The facts will further indicate that the Vitamin D product portfolio and components that are involved in this matter are not owned by Genzyme but currently rest in the public domain.

“When all the facts are laid out we are confident that the matter will be resolved in favor of Cytochroma and its employees.”

For information contact:

Eric J. Messner
Vice President
Commercial Operations
905-479-5306 ext. 338
eric.messner@cytochroma.com

< go back >